Presenter: James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
0:00
In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer. At the conclusion of this activity, participants will be able…
This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now
Login Join Now
Latest Podcasts
BS Medicine Episode #571: PREMIUM – Antibiotics and Lipids
In episode 571, James and Mike talk about 2 new papers – we learn what antibiotics we can use for community-acquired pneumonia and we also talk about the prevalence and…
BS Medicine Episode #570: Statistics made simple and relevant – we promise – PART III
In episode 570, James and Mike finish their trilogy on statistics. We take what we discussed in the previous podcasts and go through a couple of examples that will hopefully…
BS Medicine Episode #569: Statistics made simple and relevant – we promise – PART II
In episode 569, James and Mike continue to go over what statistics really show – we focus on what inferential statistics can and cannot do, what a p value means…
May 26, 2021
Presenter(s):
James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
Please provide any additional comments (optional).